Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Quark Pharmaceuticals
With
Pfizer
DEGAS termination decision date was December 17, 2010. Rationale: the objectives of the study could no longer be achieved. The study was not terminated for safety.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with Diabetes Mellitus (Type 1 or Type 2) Showing Diabetic Macular Edema in the Eye.
You may not be if
Proliferative Diabetic Retinopathy in the Study Eye.
